Holdings
Biotechnology Ultrasector Profund
As of Jul 31, 2026, Biotechnology Ultrasector Profund reported 146 positions worth US$92.8M. Largest: Apogee Therapeutics, Inc., Oruka Therapeutics, Inc. and Dianthus Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Apogee Therapeutics, Inc. | 11,447 | US$1.53M | −8,672 | Jul 31, 2026 |
| Oruka Therapeutics, Inc. | 14,788 | US$1.43M | +1,302 | Jul 31, 2026 |
| Dianthus Therapeutics, Inc. | 12,390 | US$1.32M | +1,990 | Jul 31, 2026 |
| Erasca, Inc. | 70,819 | US$1.29M | −13,112 | Jul 31, 2026 |
| Twist Bioscience Corporation | 13,972 | US$1.28M | −18,091 | Jul 31, 2026 |
| Kymera Therapeutics, Inc. | 12,103 | US$1.25M | −6,328 | Jul 31, 2026 |
| Spyre Therapeutics, Inc. | 12,611 | US$1.24M | −6,350 | Jul 31, 2026 |
| Revolution Medicines, Inc. | 6,567 | US$1.23M | −8,520 | Jul 31, 2026 |
| Cg Oncology, Inc. | 17,241 | US$1.23M | −5,404 | Jul 31, 2026 |
| Protagonist Therapeutics, Inc. | 8,952 | US$1.22M | −6,621 | Jul 31, 2026 |